Subtopic Deep Dive
Arrhythmogenic Right Ventricular Cardiomyopathy in Athletes
Research Guide
What is Arrhythmogenic Right Ventricular Cardiomyopathy in Athletes?
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) in athletes involves exercise-induced fibrofatty replacement of right ventricular myocardium leading to ventricular arrhythmias and sudden cardiac death risk.
ARVC diagnostic criteria originated from 1994 Task Force proposals, revised in 2010 by Marcus et al. (Circulation, 2628 citations) and Marcus et al. (European Heart Journal, 1572 citations) to include imaging and genetic markers. Exercise exacerbates ARVC progression in athletes, as noted in consensus statements like Maron et al. (2004, Circulation, 596 citations) on sports participation restrictions. Over 10,000 citations across listed papers highlight its clinical relevance.
Why It Matters
ARVC screening in athletes prevents sudden cardiac death, with Marcus et al. (2010) criteria enabling early diagnosis via MRI and ECG, reducing mortality in young competitors. Priori (2001) Task Force identified ARVC as a key SCD cause, informing preparticipation protocols cited in Maron et al. (2004). Towbin et al. (2019) consensus guides risk stratification, limiting high-intensity training to avert fibrofatty infiltration accelerated by endurance exercise. Gerull et al. (2004) linked plakophilin-2 mutations to 40% of cases, supporting genetic testing in athletic cohorts per Ackerman et al. (2011).
Key Research Challenges
Exercise Trigger Diagnosis
Distinguishing exercise-induced ARVC progression from physiologic adaptations challenges clinicians, as athletes show RV remodeling mimicking pathology. Marcus et al. (2010, Circulation) criteria require multimodal imaging, but sensitivity drops in early athletic stages. Priori et al. (2013) consensus notes arrhythmia provocation variability during stress testing.
Genetic Risk Stratification
Plakophilin-2 mutations (Gerull et al., 2004, Nature Genetics, 821 citations) predominate, yet penetrance varies with exercise intensity, complicating athlete counseling. Ackerman et al. (2011, Heart Rhythm, 1448 citations) recommend testing but highlight interpretation gaps for desmosomal genes. Family screening protocols lack athlete-specific validation.
Sudden Death Prevention
Balancing sports benefits against SCD risk drives protocol debates, with Maron et al. (2004) restricting participation yet facing compliance issues. Towbin et al. (2019) stratify by VT inducibility, but long-term exercise cessation efficacy remains unproven in large cohorts. Priori (2001) underscores ARVC's 20% SCD contribution in young athletes.
Essential Papers
Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
Gregory M. Marcus, William J. McKenna, Duane L. Sherrill et al. · 2010 · Circulation · 2.6K citations
Background— In 1994, an International Task Force proposed criteria for the clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) that facilitated recognition and ...
HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes
Silvia G. Priori, Arthur A.M. Wilde, Minoru Horie et al. · 2013 · Heart Rhythm · 1.9K citations
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed Modification of the Task Force Criteria
Gregory M. Marcus, William J. McKenna, D. Sherrill et al. · 2010 · European Heart Journal · 1.6K citations
The present modifications of the Task Force Criteria represent a working framework to improve the diagnosis and management of this condition. Clinical Trial Registration clinicaltrials.gov Identifi...
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
Michael J. Ackerman, Silvia G. Priori, Stephan Willems et al. · 2011 · Heart Rhythm · 1.4K citations
Task Force on Sudden Cardiac Death of the European Society of Cardiology
Silvia G. Priori · 2001 · European Heart Journal · 899 citations
Why a Task Force on sudden cardiac deathThis comprehensive, educational document on sudden cardiac death is an extensive review that was deemed necessary for two reasons: first, major studies have ...
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
Michael J. Ackerman, Silvia G. Priori, Stephan Willems et al. · 2011 · EP Europace · 896 citations
PreambleThis international consensus statement provides the state of genetic testing for the channelopathies and cardiomyopathies.It summarizes the opinion of the international writing group member...
Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy
Brenda Gerull, Arnd Heuser, Thomas Wichter et al. · 2004 · Nature Genetics · 821 citations
Reading Guide
Foundational Papers
Start with Marcus et al. (2010, Circulation, 2628 citations) for core diagnostic criteria, then Marcus et al. (2010, European Heart Journal, 1572 citations) revisions, followed by Maron et al. (2004, Circulation, 596 citations) for athlete restrictions—these establish clinical and sports-specific foundations.
Recent Advances
Study Towbin et al. (2019, Heart Rhythm, 765 citations) for updated risk stratification and management; Hayashi et al. (2015, Circulation Research, 677 citations) for SCD epidemiology in athletes.
Core Methods
Task Force Criteria scoring (Marcus 2010); cardiac MRI for RV volumetry; genetic sequencing for PKP2/DSP (Gerull 2004, Ackerman 2011); exercise stress testing per Priori et al. (2013).
How PapersFlow Helps You Research Arrhythmogenic Right Ventricular Cardiomyopathy in Athletes
Discover & Search
Research Agent uses searchPapers('ARVC athletes exercise fibrofatty') to retrieve Marcus et al. (2010, Circulation, 2628 citations), then citationGraph reveals 1500+ downstream papers on athletic cohorts, while findSimilarPapers expands to exercise-modified Task Force criteria. exaSearch queries 'sudden cardiac death ARVC endurance sports' yielding Maron et al. (2004) and Priori (2001).
Analyze & Verify
Analysis Agent applies readPaperContent on Towbin et al. (2019) to extract risk scores, verifies diagnostic criteria overlap with Marcus et al. (2010) via verifyResponse (CoVe), and runs PythonAnalysis for GRADE grading of evidence levels across 10 consensus papers, confirming high-quality imaging recommendations. Statistical verification computes mutation prevalence from Gerull et al. (2004) datasets.
Synthesize & Write
Synthesis Agent detects gaps in athlete-specific ARVC progression models post-Maron et al. (2004), flags contradictions between exercise restriction efficacy in Priori et al. (2013) vs. Towbin et al. (2019), and generates exportMermaid flowcharts of diagnostic pathways. Writing Agent uses latexEditText for protocol drafts, latexSyncCitations integrates 20 papers, and latexCompile produces camera-ready reviews.
Use Cases
"Extract prevalence stats of plakophilin-2 mutations in athlete ARVC cohorts from papers."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas aggregation of Gerull et al. 2004 data across 5 citing papers) → CSV table of mutation rates by sport type.
"Draft LaTeX review on ARVC screening protocols for competitive athletes."
Synthesis Agent → gap detection on Marcus 2010 criteria → Writing Agent → latexEditText (protocol outline) → latexSyncCitations (15 papers) → latexCompile → PDF manuscript with synced refs.
"Find analysis code for ARVC ECG datasets in athlete studies."
Research Agent → paperExtractUrls (Hayashi 2015) → paperFindGithubRepo → githubRepoInspect → Verified Jupyter notebook for VT detection stats in sports cohorts.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ ARVC papers via searchPapers → citationGraph → GRADE grading, producing structured report on exercise modifiers citing Marcus et al. (2010). DeepScan applies 7-step CoVe analysis to verify Maron et al. (2004) recommendations against recent consensus like Towbin et al. (2019). Theorizer generates hypotheses on fibrofatty progression models from Priori (2001) and Gerull et al. (2004) genetics.
Frequently Asked Questions
What defines ARVC in athletes?
ARVC features fibrofatty RV replacement causing arrhythmias, worsened by exercise; Marcus et al. (2010, Circulation) criteria score major/minor features in imaging, ECG, genetics, family history.
What are main diagnostic methods?
Revised Task Force Criteria (Marcus et al., 2010, European Heart Journal) integrate cardiac MRI for RV dysfunction, Holter for PVCs, and genetic tests for desmosomal mutations like PKP2 (Gerull et al., 2004).
What are key papers?
Marcus et al. (2010, Circulation, 2628 citations) foundational criteria; Ackerman et al. (2011, Heart Rhythm, 1448 citations) genetic testing; Towbin et al. (2019, Heart Rhythm, 765 citations) management consensus.
What open problems exist?
Optimal exercise thresholds for mutation carriers unestablished; long-term impact of detraining on fibrofatty infiltration unclear; athlete-specific risk scores lacking prospective validation beyond Priori (2001) frameworks.
Research Cardiovascular Effects of Exercise with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Arrhythmogenic Right Ventricular Cardiomyopathy in Athletes with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers